Herbal drug-drug interaction and adverse drug reactions;Phytopharmaka als ursache von unerwünschten arzneimittelwirkungen

Therapeutische Umschau

Volumn 68, Issue 1, 2011, Pages 54-57

  Hafner Blumenstiel, Verena ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BARBITURIC ACID DERIVATIVE; CYTOCHROME P450 3A4; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HYPERICUM PERFORATUM EXTRACT; IMMUNOSTIMULATING AGENT; IMMUNOSUPPRESSIVE AGENT; VALERIAN;

ADVERSE DRUG REACTION; DRUG INTERACTION; ECHINACEA; GINKGO BILOBA; GINSENG; HERBAL MEDICINE; HUMAN; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT; SEDATION; SIDE EFFECT;

CYTOCHROME P-450 CYP3A; ECHINACEA; ENZYME INDUCTION; GINKGO BILOBA; HERB-DRUG INTERACTIONS; HUMANS; HYPERICUM; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; PLANT PREPARATIONS; VALERIAN;

EID: 78650675350     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930/a000120     Document Type: Review

References (15)

1. Müller-Oerlinghausen B, Lasek R, Düppenbecker H, Munter K-H. eds. Handbuch der unerwünschten Arz neimittelwirkungen. 1. Auflage. München: Urban & Fischer 1999 : 650-69.
2. Martin-Facklam M, Rieger K, Riedel K-D, Burhenne J, Walter-Sack I, Haefeli WE. Undeclared exposure to St. John's Wort in hospitalized patients. Br J Clin Pharmacol. 2004; 58: 437-41.
3. Rieger K, Scholer A, Arnet I, et al. High prevalence of unknown comedication in hospitalised patients. Eur J Clin Pharmacol. 2004; 60: 363-8.
4. Hafner V, Grün B, Markert C, Czock D, Mikus G, Haefeli WE. Drug interactions. Internist (Berl). 2010; 51: 359-69.
5. Wurglics M, Westerhoff K, Kaunzinger A, et al. Comparison of German St. John's wort products according to hyperforin and total hypericin content. J Am Pharm Ass. 2001; 41: 560-6.
6. Mueller SC, Majcher-Peszynska J, Uehleke B, et al. The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose. Eur J Clin Pharmacol. 2006; 62: 29-36. (Pubitemid 43106313)
7. Borrelli F, Izzo AA. Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. AAPS J. 2009; 11: 710-27.
8. Fattinger K, Meier-Abt A. Interaktionen zwischen Phytopharmaka und Arzneimitteln. Schweiz Med Forum. 2003; 29/30: 693-700.
9. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009; 69: 1777-98.
10. Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther. 2004; 76: 428-40.
11. Fugh-Berman A. Herb-drug interactions. Lancet. 2000; 355: 134-8.
12. Kloft C, Kellermann A. Bleeding caused by Ginkgo biloba extract? Pharm Unserer Zeit. 2009; 38: 440-6.
13. Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drugherb interactions. Arch Intern Med. 1998; 158: 2200-11.
14. Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care. 1995; 18: 1373-5.
15. Yuan CS, Wei G, Dey L, et al. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial. Ann Intern Med. 2004; 141: 23-7.